Home  >  Products  >  GP5 (glycoprotein V (platelet) ) Blocking Peptide (the C terminal of GP5)(100ug)
GP5 (glycoprotein V (platelet) ) Blocking Peptide (the C terminal of GP5)(100ug)

GP5 (glycoprotein V (platelet) ) Blocking Peptide (the C terminal of GP5)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GP5 Antibody (ARP63287_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63287
Size: 100ug
Weight: 62kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Human platelet glycoprotein V (GP5) is a part of the Ib-V-IX system of surface glycoproteins that constitute the receptor for von Willebrand factor and mediate the adhesion of platelets to injured vascular surfaces in the arterial circulation, a critical initiating event in hemostasis. The main portion of the receptor is a heterodimer composed of 2 polypeptide chains, an alpha chain and a beta chain, that are linked by disulfide bonds. The complete receptor complex includes noncovalent association of the alpha and beta subunits with platelet glycoprotein IX and GP5. Mutations in GP1BA, GP1BB, and GP9 have been shown to cause Bernard-Soulier syndrome, a bleeding disorder.
Alternative names: CD42d
See Full Product Listings >